Karger Publishers New Journal – Immune System

Expands Its Open Access Portfolio with an Up-and-Coming Publication for Basic and Applied Immunological Research

Karger Publishers’ new journal Immune System features Open Access-based original research and reviews reporting on translational and clinical studies encompassing all fields of immunology with the intention of bridging clinical research with preclinical and translational investigations. With the launch of this new journal, the company seeks to fulfill a strong need in the scientific community for an open and up-and-coming forum for current basic and applied immunological research. The journal will emphasize evidence-based clinical and laboratory research with statistically valid results that clearly help to advance the future of science.

The world-renowned editors-in-chief, Désirée Larenas-Linnemann, Hospital Medica Sur, Mexico City, Mexico, along with Florent Ginhoux, A*Star, Singapore, are specifically welcoming intra- and interdisciplinary research on Environmental Immunology, Immunomics, Immunotherapy, including but not restricted to immune aspects of allergies, respiratory tract, skin, autoimmune and neurodegenerative disorders. The editors are looking for cutting-edge scientific research, systematic reviews, well-elaborated clinical cases and case-series. The transfer of information from fundamental research to clinical research and clinical practice – that is from lab bench to bed — is particularly welcome.

“Immune System is an innovative Open Access journal, welcoming articles with a broad background from basic science to clinical research, as long as the manuscript focuses on certain aspects of our immune response,” states editor-in-chief Désirée Larenas-Linnemann.”

“I’m delighted to announce the launch of our new Karger journal, Immune System, committed to advancing the frontiers of immunology by showcasing and pioneering discoveries that unite clinical and preclinical research. Let’s collaboratively shape a future for immunological research, unbound by limitations” says Marco Casola, Publications Manager of Immunology and Allergy.

Submissions will be accepted on a rolling basis via the journal’s homepage at https://karger.com/ims.

SourceKarger

Hot this week

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."